Molecular genetics studies in Polish Charcot-Marie-Tooth families

Folia Neuropathologica

Volumn 43, Issue 2, 2005, Pages 65-73

  Kochański, Andrzej ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Charcot Marie Tooth disease; Gene mapping; Molecular diagnostics; Mutation screening; Pathogenic effect of mutations; Phenotype genotype correlations

Indexed keywords

MYELIN PROTEIN; PERIPHERAL MYELIN PROTEIN 22;

AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CHROMOSOME 17P; CHROMOSOME DELETION; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LINKAGE ANALYSIS; MOLECULAR GENETICS; ONSET AGE; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; POLAND; PREVALENCE; REVIEW; X CHROMOSOME LINKAGE;

EID: 22144497770     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Antonellis A, Ellsworth RE, Sambuughin N, Puls J, Abel A, Lee-Lin SQ, Jordanova A, Kremenski J, Christodoulou K, Middleton L, Sivakumar K, Ionasescu V, Funalot B, Vance JM, Goldfarb LG, Fischbeck KH, Gren LD. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 2003; 72: 1293-1299.
2. Baxter RV, Ben Othmane K, Rochelle JM, Stajich JE, Hulette C, De Knight S, Hentati F, Ben Hamida M, Bel S, Stenger JE, Gilbert JR, Percak-Vance MA, Vance JM. Ganglioside induced differentiation - associated protein-1 is mutated in Charcot-Marie-Tooth disease type 4A/8q21. Nat Genet 2002; 30: 21-22.
3. Ben Othmane K, Middleton LT, Loprest LJ, Wilkinson KM, Lennon F, Rozear MP, Stajich JM, Gaskell PC, Roses AD, Pericak-Vance MA, et al. Localization of a gene (CMT2A) for autosomal dominant Charcot-Marie-Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity. Genomics 1993; 17 (2): 370-375.
4. Bergoffen J, Scherer SS, Wang S, Oronzi Scott M, Bone LJ, Paul DL, Chen K, Lensch MW, Chance PF, Fischbeck KH. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993; 262: 2039-2042.
5. Bird TD, Ott J, Giblett ER. Genetic linkage evidence for heterogeneity in Charcot-Marie-Tooth neuropathy (HMSN type I). Am J Hum Genet 1982; 34: 388-394.
6. Boerkoel CF, Takashima H, Stankiewicz P, Garcia CA, Leber SM, Rhee-Morris, Lupski JR. Periaxin mutations cause recessive Dejerine Sottas neuropathy. Am J Hum Genet 2001; 68: 325-333.
7. Boerkoel CF, Takashima H, Garcia CA, Olney RK, Johnson J, Berry K, Russo P, Kennedy S, Teebi AS, Scavina M, Williams LL, Mancias P, Butler IJ, Krajewski K, Shy M, Lupski JR. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 2002; 51: 190-201.
8. Bolino A, Brancolini V, Bono F, Bruni A, Gambardella A, Romeo G, Quattrone A, Devoto M. Localization of a gene responsible for a recessive demyelinating neuropathy with focally folded myelin sheaths to chromosome 11q23 by homozygosity mapping and haplotype sharing. Hum Mol Genet 1996; 5: 1051-1054.
9. Bolino A, Muglia M, Conforti FL, Leguern E, Salih MA, Georgiou DM, Christodoulou K, Hausmanowa-Petrusewicz I, Mandich P, Schenone A, Gambardella A, Bono F, Quattrone A, Devoto M, Monaco AP. Charcot-Marie-Tooth type 4B is caused by mutation in the gene encoding myotubularin-related protein-2. Nat Genet 2000; 2000: 25: 17-19.
10. Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, Swanson PD, Odelberg SJ, Distecha CM, Bird TD. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993; 72: 143-151.
11. Cuesta A, Pedrola L, Sevilla T, Garcia-Planells J, Chumillas MJ, Mayodromo F, LeGuern E, Marin I, Vilchez JJ, Palau F. The gene encoding ganglioside-induced differentiation protein-1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 2001; 30: 22-25.
12. De Sandre-Giovannoli A, Chaouche M, Kozlov S, Vallat JM, Tazir M, Kassouri N, Szepetowski P, Hammodouche T, Vandenberghe A, Stewart CL, Grid D, Levy N. Homozygous defects in LMNA encoding lamin A/C nuclear - envelope protein, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse 2002; 70: 726-736.
13. Gabreels-Festen A, Van Beersen S, Eshuis L, Le Guern E, Gabreels F, van Englen B, Mariman E. Study on the gene and phenotypical characterization of autosomal recessive demyelinating neuropathy (Charcot-Marie-Tooth disease) with a gene locus on chromosome 5q23-q33. J Neurol Neurosurg Psych 1999; 66: 569-574.
14. Gal A, Mucke J, Theile H, Wieacker PF, Ropers HH, Wienker TF. X-linked dominant Charcot-Marie-Tooth disease: suggestion of linkage with a cloned DNA sequence from the proximal Xq. Hum Genet 1985; 70: 38-42.
15. Guilbot A, Williams A, Ravise N, Verny C, Brice A, Sherman K, Brophy PJ, LeGuern E, Delague V, Bareil C, Megarbane A, Claustres M. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet 2001; 15: 415-421.
16. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980; 103: 259-280.
17. Hayasaka K, Himoro M, Sato W, Takada G, Uyemura K, Shimizu N, Bird TD, Conneally PM, Chance PF. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet 1993; 5: 31-34.
18. Holmberg BH, Holmgren G, Nelis E, Van Broeckhoven C, Westerberg B. Charcot-Marie-Tooth disease in northern Sweden: Pedigree analysis and the presence of the duplication within chromosome 17p11.2. J Med Genet 1994; 1994; 31: 435-441.
19. Ionaesescu VV, Trofatter J, Haines JL, Ionasescu R, Searby C. X-linked recessive Charcot-Marie-Tooth neuropathy: clinical and genetic study. Muscle Nerve 1992; 15 (3): 368-373.
20. Ismailov SM, Fedotov VP, Dadali EL, Polyakov A, Van Broeckhoven C, Ivanov VI, De Jonghe P, Timmerman V, Evgrafov O. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2F) maps to chromosome 7q11-q21. Eur J Hum Genet 2001; 9: 645-650.
21. Jordanova A, De Jonghe P, Boerkoel C, Takashima H, De Vriendt E, Ceuterick C, Martin JJ, Butler JI, Mancias P, Papasozomenos Sch, Terespolsky D, Potocki L, Brown CW, Shy M, Rita DA, Tournev I, Kremensky J, Lupski JR, Timmerman V. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 2003; 126: 590-597.
22. Jordanova A, Thomas FP, Guergueltcheva V, Tournev I, Gondim FA, Isphekova B, De Vriendt E, Jacobs A, Litvinenko I, Ivacova N, Buzkov B, De Jonghe P, Kremensky I, Timmerman V. Dominant intermediate Charcot-Marie-Tooth type C maps to chromosome 1p34-p35. Am J Hum Genet 2003; 73: 1423-1430.
23. Kabzińska D, Kochański A, Perez-Olle R, Goryunov D, Drac H, Ryniewicz B, Hausmanowa-Petrusewicz I, Liem R. A novel Ile214Met substitution in the NEFL gene In two patients with Charcot-Marie-Tooth disease, mutation or polymorphism. Neurogenetics, in press.
24. Kalaydjieva L, Nikolova A, Turnev I, Petrova J, Hristova A, Isphekova B, Petkova I, Shmarov A, Stuncheva S, Middleton L, Merlini L, Trogu A, Muddle JR, King RH, Thomas PK. Hereditary motor and sensory neuropathy-Lom, a novel demyelinating neuropathy associated with deafness in Gypsies. Brain 1998; 121: 399-408.
25. Kalaydjieva L, Gresham D, Gooding R, Heather L, Baas F, de Jonghe R, Blechmidt K, Angelicheva D, Chandler D, Worsleg P, Rosenthal A, King RH, Thomas PK. N-myc downstream regulated gene 1 is mutated in hereditary motor and sensory neuropathy - Lom, Am J Hum Genet 2000; 67: 47-58.
26. Kennerson ML, Zhu D, Gardner RJ, Storey E, Merory J, Robertson SP, Nicholson GA. Dominant intermediate Charcot-Marie-Tooth neuropathy maps to chromosome 19p12-p13.2. Am J Hum Genet 2001; 69: 883-888.
27. Klein CJ, Cunningham JM, Atkinson EJ, Schaid DJ, Hebring SJ, Andersen SA, Klein DM, Dyck PJ, Litschy WJ, Thibodeou SN, Dyck PJ. The gene for HMSN2c maps to 12q23-24. A region of neuromuscular disorders. Neurology 2003; 60: 1151-1156.
28. Kochański A, Lofgren A, Jedrzejowska H, Ryniewicz B, Czarny-Ratajczak M, Barciszewska A, Samoćko J, Hausmanowa-Petrusewicz I, De-Jonghe P, Timmerman V, Latos-Bieleńska A. A novel connexin 32 missense mutation (E208G) causing Charcot-Marie-Tooth disease. Hum Mut 2001; 17: 157.
29. Kochański A, Drac H, Jedrzejowska H, Hausmanowa-Petrusewicz I. Focally folded myelin in Charcot-Marie-Tooth type 1B disease is associated with Asn131Lys mutation In Myelin Protein Zero gene-short report. Eur J Neurol 2003; 10: 547-549.
30. Kochański A, Drac H, Kabzińska D, Ryniewicz B, Rowińska-Marcińska K, Nowakowski A, Hausmanowa-Petrusewicz I. A novel MPZ gene mutation in congenital neuropathy with hypomyelination. Neurology 2004; 62: 2122-2123.
31. Kochański A, Kabzińska D, Drac H, Ryniewicz B, Rowinska-Marcinska K, Hausmanowa-Petrusewicz I. Early onset Charcot-Marie-Tooth type 1B disease caused by a novel Leu190fs mutation in the Myelin Protein Zero gene. Eur J Paediatr Neurol 2004; 8: 221-224.
32. Kochański A, Drac H, Kabzińska D, Hausmanowa-Petrusewicz I. The novel mutation, Thr65Ala, in the MPZ gene in the patient with Charcot-Marie-Tooth type 1B with focally folded myelin. Neuromuscular Disorders 2004; 14: 229-232.
33. Kochański A, Kabzińska D, Nowakowski A, Drac H, Hausmanowa-Petrusewicz I. An axonal form of CMT disease with a novel missense mutation in the myelin protein zero gene. J Peripheral Nerv System 2004; 9: 1-2.
34. Kochański A. Mutations in the Myelin Protein Zero gene result in a spectrum of CMT phenotypes. Acta Myologica 2004; XXIII: 6-9.
35. Kochański A, Kabzińska D. Molecular genetic analysis of the GJB1 gene: a study of six mutations. J Appl Genet 2004; 45 (1): 95-100.
36. Kochański A, Nowakowski A, Kawulak M, Kabzińska D, Hausmanowa-Petrusewicz I. Somatic mosaicism in Charcot-Marie-Tooth type X disease. Neurology 2004; 62: 336-337.
37. Kochański A, Kabzinska D. Two de novo Ser72Leu mutations In the peripheral Myelin Protein 22 gene in two Polish patients. Acta Biochim Pol 2004; 51: 1047-1050.
38. Kochański A, Kennerson M, Kawulak M, Ryniewicz B, Rowińska-Marcińska K, Walizada G, Nowakowski A, Hausmanowa-Petrusewicz I, Nicholson G. A mild early onset axonal Charcot-Marie-Tooth 2 disease not linked to other known Charcot-Marie-Tooth loci. Neurology 2005; 64: 533-536.
39. Lagueny A, Latour A, Vital A, Masson G, Rouanet M, Ferrer X, Vital C, Vandenberghe A. A mild recurrent neuropathy in CMT1B with a novel nonsense mutation in the extracellular domain of the MPZ gene. J Neurol Neurosurg Psych 2001; 70: 232-235.
40. Leal A, Morera B, Del Valle G, Heuss D, Kayser C, Berghoff M, Villages R, Hernandez E, Mendez M, Hennies HC, Neundorfer B, Barranter R, Reis A, Rautenstrauss B. A second locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 19q13.3. Am J Hum Genet 2001; 68: 269-274.
41. Le Guern E, Guilbot A, Kessali M, Ravise N, Tassin J, Maisonobe T, Grid D, Brice A. Homozygosity mapping of an autosomal recessive form of demyelinating Charcot-Marie-Tooth disease to chromosome 5q23-q33. Hum Mol Genet 1996; 5: 1685-1688.
42. Lehmann-Horn F. Disease-causing mutations or functional polymorphisms? Acta Myologica 2004; 23: 85-89.
43. Lupski JR, Montes de Oca-Luna R, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucado-Cardenas O, Barker DF, Killian JM, Garcia CA. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991; 66: 219-232.
44. Martin PEM, Mambetisaeva ET, Archer DA, George CH, Evans WH. Analysis of gap junction assembly using mutated connexins detected in charcot-Marie-Tooth X-linked disease. J Neurochem 2000; 74: 711-720.
45. Mersiyanova I, Perepelov A, Polyakov A, Sitnikov VF, Dadali EL, Oparin RB, Petrin AN, Evgrafov OV. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the Neurofilament-light gene. Am J Hum Genet 2000; 67: 37-46.
46. Nelis E, Van Broeckhoven C. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European Collaborative study. Eur J Hum Genet 1996; 4: 25-33.
47. Nelis E, Berciano J, Verpoorten N, Coen K, Dierick J, Van Gerven V, Combarros O, De Jonghe P, Timmerman V. Autosomal dominant axonal Charcot-Marie-Tooth disease type 2 (CMT2G) maps to chromosome 12q12-q13.3. J Med Genet 2004; 41: 193-197.
48. Nicholson GA, Valentijn LJ, Cherryson AK, Kennerson ML, Bagg TL, De Kroon RM, Ross DA, Pollard JD, Mc Leod JG, Bolhuis PA. A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nat Genet 1994; 6: 263-266.
49. Nowakowski A, Kochański A. Screening of the Myelin Protein Zero gene in fifty patients with Charcot-Marie-Tooth disease. Acta Biochim Pol 2004; 51: 273-280.
50. Priest JM, Fischbeck KH, Nouri N, Keats BJ. A locus for axonal motor - sensory neuropathy with deafness and mental retardation maps to Xq24-q26. Genomics 1995; 29: 409-412.
51. Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, Barker DF, Martin JJ, De Visser M, Bolhuis PA. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT1a). Neuromusc Disord 1991; 1: 93-97.
52. Roa BR, Garcia CA, Suter U, Kulpa DA, Wise CA, Mueller J, Welcher AA, Snipes GJ, Shooter EM, Patel PJ. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 1993; 329: 96-101.
53. Rozear MP, Pericak-Vance MA, Fischbeck K, Stajich JM, Gaskell PCJr, Krendel DA, Graham DG, Dawson DV, Roses AD. Hereditary motor and sensory neuropathy X-linked: a half century follow up. Neurology 1987; 37: 1460-1465.
54. Saifi GM, Szigeti K, Wiszniewski W, Shy ME, Krajewski K, Hausmanowa-Petrusewicz I, Kochański A, Reeser S, Lupski JR. SIMPLE/LITAF mutations in Charcot-Marie-Tooth disease and the potential role of the protein products in peripheral nerve transcriptional regulation and protein degradation. Hum Mut, in press.
55. Senderek J, Bergmann C, Weber S, Katelsen UP, Schorle H, Rudnik-Schoneborn S, Buttner R, Buchheim E, Zerres K. Mutation of the SBF2 gene encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum Mol Genet 2003; 12: 349-356.
56. Senderek J, Bergmann C, Stendel C, Kirfel J, Verpoorten N, De Jonghe P, Timmerman V, Chrast R, Verheijen MH, Lemke G, Battologlu E, Parman Y, Erdem S, Tan E, Topaloglu H, Hahn A, Muller-Felber W, Rizzutto N, Fabrizi GM, Stuhrmann M, Rudnik-Schoneborn S, Zuchner S, Schroder MJ, Buchheim E, Straub V, Klepper J, Huehne K, Rautenstrauss B, Buttner R, Nelis E, Zerres K. Mutations in a gene encoding a novel SH3/TPR Domain Protein cause autosomal resessive Charcot-Marie-Tooth type 4C neuropathy. Am J Hum Genet 2003; 73: 1106-1119.
57. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 1974; 6: 98-118.
58. Street VA, Goldy JD, Golden AS, Tempel BL, Bird TD, Chance PF. Mapping of Charcot-Marie-Tooth disease type 1C to chromosome 16p identifies a novel locus for demyelinating neuropathies. Am J Hum Genet 2002; 70: 244-250.
59. Street VA, Bennett CL, Goldy JD, Shirk AJ, Kleopa KA, Tempel BL, Lipe HP, Scherrer SS, Bird TD, Chance PF. Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 2003; 60: 22-26.
60. Tang B, Luo W, Xia K, Xiao J, Jiang H, Shen L, Tang J, Zhao G, Cai F, Pan Q, Dai H, Yang Q, Xia J, Evgrafov OV. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2L) maps to chromosome 12q24. Hum Genet 2004; 114: 527-533.
61. Thomas PK, Kalaydjieva L, Youl B, Rogers T, Angelicheva D, King RH, Guergeltcheva V, Colomer J, Lupu C, Corches AP, Popa G, Merlini L, Schmarov A, Muddle JR, Nourallah M, Tournev I. Hereditary motor and sensory neuropathy-russe: new autosomal recessive neuropathy in Balkan Gypsies. Ann Neurol 2001; 50: 452-457.
62. Web site: www.molgen.ua.ac.be
63. Warner LE, Mancias P, Butler IJ, Mc Donald CM, Keppen L, Koob KG, Lupski JR. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998; 18: 382-384.
64. Warner LE, Hilz MJ, Appel SH, Killian JM, Kolodny EH, Karpati G, Carpenter S, Watters GV, Wheeler C, Witt D, Bedell A, Nelis E, Van Broeckhoven C. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron 1996; 17: 451-460.
65. Wise CA, Garcia CA, Davis SN, Heju Z, Pentao L, Patel PJ, Lupski JR. Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggests a high frequency of the CMT1A Duplication. Am J Hum Genet 1993; 53: 853-863.
66. Verhoeven K, De Jonghe P, Coen K, Verpoorten N, Auer-Grumbach M, Kwon JM, Fitz Patrick D, Schmidding P, De Vriendt E, Jacobs A, Van Gerwen V, Wagner K, Hartung HP, Timmerman V. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 2003; 72: 722-727.
67. Verhoeven K, Villanova M, Rossi A, Malandrini A, De Jonghe P, Timmerman V. Localization of the gene for the intermediate form of Charcot-Marie-Tooth to chromosome 10q24.1-q25.1. Am J Hum Genet 2001; 69: 889-894.
68. Yamamoto M, Yoshihara T, Hattori N, Sobue G. Glu528del in NEFL is a polymorphic variant rather than a disease -causing mutation for Charcot-Marie-Tooth disease in Japan. Neurogenetics 2004; 5: 75-77.
69. Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, Yang HW, Terada S, Nakata T, Takei Y, Saito M, Tsuji S, Hayashi Y, Hirokava N. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 2001; 105: 587-597.
70. Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri, Rochelle J, Dadali EL, Zappa M, Nelis E, Patitucci A, Senderek J, Parman Y, Evgrafov O, Jonghe PD, Takahushi T, Tsuji S, Pericak-Vance MA, Quattrone A, Battoglu E, Polyakov AV, Timmerman V, Schroder JM, Vance JM. Mutations in the mitochondrial GTPase mitofusin 2 cause CMT neuropathy type 2A. Nat Genet 2004; 36: 449-451.